Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2009

Open Access 01-12-2009 | Research

Multinucleation followed by an acytokinetic cell division in myxofibrosarcoma with giant cell proliferation

Authors: Takashi Ariizumi, Akira Ogose, Hiroyuki Kawashima, Tetsuo Hotta, Hajime Umezu, Naoto Endo

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2009

Login to get access

Abstract

Background

Multinucleated cells are frequently seen in association with a malignant neoplasm. Some of these multinucleated cells are considered to be neoplastic. The mechanism of neoplastic multinucleation remains unknown, but is considered to be induced by either cell-cell fusion or acytokinetic cell division. Myxofibrosarcoma consists of spindled and pleomorphic tumor cells and bizarre multinucleated giant cells. Some of these multinucleated cells are considered to be neoplastic.

Methods

We studied the mitotic activity of the multinucleated cells by Ki-67 immunohistochemistry, and the dynamics and differentiation by live-cell video microscopy in the two myxofibrosarcoma cell lines to determine whether the mechanism of multinucleation is cell-cell fusion or acytokinetic cell division

Results

A Ki-67 immunohistochemical analysis revealed a high positive rate of multinucleated cells, as well as mononuclear cells, and mitotic ability was shown in the multinucleated cells. In live-cell video microscopy, most of the multinucleated cells were induced via the process of acytokinetic cell division.

Conclusion

The current study indicates that a vulnerability of the cytoskeleton components, such as the contractile ring, causes multinucleation to occur from the telophase to the cytokinesis of the cell cycle.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen EH, Grote E, Mohler W, Vignery A: Cell-cell fusion. FEBS Lett. 2007, 581: 2181-93. 10.1016/j.febslet.2007.03.033.CrossRef Chen EH, Grote E, Mohler W, Vignery A: Cell-cell fusion. FEBS Lett. 2007, 581: 2181-93. 10.1016/j.febslet.2007.03.033.CrossRef
2.
go back to reference Miyamoto T, Suda T: Differentiation and function of osteoclasts. Keio J Med. 2003, 52: 1-7.CrossRef Miyamoto T, Suda T: Differentiation and function of osteoclasts. Keio J Med. 2003, 52: 1-7.CrossRef
3.
go back to reference Junqueira LC, Carneiro J: Connective Tissue. Basic histology text & atlas. 2005, New York: The McGraw-Hill Companies, 91-122. 11 Junqueira LC, Carneiro J: Connective Tissue. Basic histology text & atlas. 2005, New York: The McGraw-Hill Companies, 91-122. 11
4.
go back to reference Stevens A, Lowe JS: Liver. Human histology. 1997, St. Louis: Mosby, 215-226. 2 Stevens A, Lowe JS: Liver. Human histology. 1997, St. Louis: Mosby, 215-226. 2
5.
go back to reference Stricker TP, Kumar V: Neoplasia. Robbins basic pathology. Edited by: Kumar V, Abbas AK, Fausto N, Mitchell RN. 2007, Philadelphia: Saunders Elsevier, 173-223. 8 Stricker TP, Kumar V: Neoplasia. Robbins basic pathology. Edited by: Kumar V, Abbas AK, Fausto N, Mitchell RN. 2007, Philadelphia: Saunders Elsevier, 173-223. 8
6.
go back to reference Lee FD, Anderson JR: Lympho-reticular tissues. Muir's textbook of pathology. Edited by: Anderson JR. 1985, London: Edward Arnold, Capter 18: 12 Lee FD, Anderson JR: Lympho-reticular tissues. Muir's textbook of pathology. Edited by: Anderson JR. 1985, London: Edward Arnold, Capter 18: 12
7.
go back to reference Mentzel T, Berg Van den E, Molenaar WN: Myxofibrosarcoma. Pathology and genetics of tumours of soft tissue and bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, Lyon: IARCPress, 102-103. Mentzel T, Berg Van den E, Molenaar WN: Myxofibrosarcoma. Pathology and genetics of tumours of soft tissue and bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, Lyon: IARCPress, 102-103.
8.
go back to reference Hatano H, Tokunaga K, Ogose A, Imaizumi S, Hayami T, Yamagiwa H, Hotta T, Endo N, Takahashi H, Naito M: Origin of histiocyte-like cells and multinucleated giant cells in malignant fibrous histiocytoma: neoplastic or reactive?. Pathol Int. 1999, 49: 14-22. 10.1046/j.1440-1827.1999.00819.x.CrossRef Hatano H, Tokunaga K, Ogose A, Imaizumi S, Hayami T, Yamagiwa H, Hotta T, Endo N, Takahashi H, Naito M: Origin of histiocyte-like cells and multinucleated giant cells in malignant fibrous histiocytoma: neoplastic or reactive?. Pathol Int. 1999, 49: 14-22. 10.1046/j.1440-1827.1999.00819.x.CrossRef
9.
go back to reference Kawashima H, Ogose A, Gu W, Nishio J, Kudo N, Kondo N, Hotta T, Umezu H, Tohyama T, Nishijima H, Iwasaki H, Endo N: Establishment and characterization of a novel myxofibrosarcoma cell line. Cancer Genet Cytogenet. 2005, 161: 28-35. 10.1016/j.cancergencyto.2005.02.003.CrossRef Kawashima H, Ogose A, Gu W, Nishio J, Kudo N, Kondo N, Hotta T, Umezu H, Tohyama T, Nishijima H, Iwasaki H, Endo N: Establishment and characterization of a novel myxofibrosarcoma cell line. Cancer Genet Cytogenet. 2005, 161: 28-35. 10.1016/j.cancergencyto.2005.02.003.CrossRef
10.
go back to reference Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, Imamura T, Ogawa M, Masai H, Miyawaki A: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell. 2008, 132: 487-98. 10.1016/j.cell.2007.12.033.CrossRef Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, Imamura T, Ogawa M, Masai H, Miyawaki A: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell. 2008, 132: 487-98. 10.1016/j.cell.2007.12.033.CrossRef
11.
go back to reference Hatanaka T, Hatanaka Y, Tsuchida J, Ganapathy V, Setou M: Amino acid transporter ATA2 is stored at the trans-Golgi network and released by insulin stimulus in adipocytes. J Biol Chem. 2006, 281: 39273-84. 10.1074/jbc.M604534200.CrossRef Hatanaka T, Hatanaka Y, Tsuchida J, Ganapathy V, Setou M: Amino acid transporter ATA2 is stored at the trans-Golgi network and released by insulin stimulus in adipocytes. J Biol Chem. 2006, 281: 39273-84. 10.1074/jbc.M604534200.CrossRef
12.
go back to reference Chambers TJ: Multinucleate giant cells. J Pathol. 1978, 126: 125-48. 10.1002/path.1711260302.CrossRef Chambers TJ: Multinucleate giant cells. J Pathol. 1978, 126: 125-48. 10.1002/path.1711260302.CrossRef
13.
go back to reference Vignery A: Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol. 2000, 81: 291-304. 10.1111/j.1365-2613.2000.00164.x.CrossRef Vignery A: Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol. 2000, 81: 291-304. 10.1111/j.1365-2613.2000.00164.x.CrossRef
14.
go back to reference Drexler HG, Gignac SM, Hoffbrand AV, Minowada J: Formation of multinucleated cells in a Hodgkin's-disease-derived cell line. Int J Cancer. 1989, 43: 1083-90. 10.1002/ijc.2910430622.CrossRef Drexler HG, Gignac SM, Hoffbrand AV, Minowada J: Formation of multinucleated cells in a Hodgkin's-disease-derived cell line. Int J Cancer. 1989, 43: 1083-90. 10.1002/ijc.2910430622.CrossRef
15.
go back to reference Re D, Benenson E, Beyer M, Gresch O, Draube A, Diehl V, Wolf J: Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236. Am J Hematol. 2001, 67: 6-9. 10.1002/ajh.1068.CrossRef Re D, Benenson E, Beyer M, Gresch O, Draube A, Diehl V, Wolf J: Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236. Am J Hematol. 2001, 67: 6-9. 10.1002/ajh.1068.CrossRef
16.
go back to reference Küppers R, Bräuninger A, Müschen M, Distler V, Hansmann ML, Rajewsky K: Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions. blood. 2001, 97: 818-21. 10.1182/blood.V97.3.818.CrossRef Küppers R, Bräuninger A, Müschen M, Distler V, Hansmann ML, Rajewsky K: Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions. blood. 2001, 97: 818-21. 10.1182/blood.V97.3.818.CrossRef
17.
go back to reference Folpe AL, Gown AM: Immunohistochemistry for analysis of soft tissue tumors. Enzinger and Weiss's soft tissue tumors. Edited by: Weiss SW, Goldblum JR. 2008, St. Louis: Mosby, 129-174. 5 Folpe AL, Gown AM: Immunohistochemistry for analysis of soft tissue tumors. Enzinger and Weiss's soft tissue tumors. Edited by: Weiss SW, Goldblum JR. 2008, St. Louis: Mosby, 129-174. 5
18.
go back to reference Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984, 133: 1710-1715. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984, 133: 1710-1715.
19.
go back to reference Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J: Cell motility and shape I. Molecular cell biology. 2000, New York: W. H. Freeman and company, 752-794. 4 Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J: Cell motility and shape I. Molecular cell biology. 2000, New York: W. H. Freeman and company, 752-794. 4
Metadata
Title
Multinucleation followed by an acytokinetic cell division in myxofibrosarcoma with giant cell proliferation
Authors
Takashi Ariizumi
Akira Ogose
Hiroyuki Kawashima
Tetsuo Hotta
Hajime Umezu
Naoto Endo
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2009
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-28-44

Other articles of this Issue 1/2009

Journal of Experimental & Clinical Cancer Research 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine